325 related articles for article (PubMed ID: 18444492)
1. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.
Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E
Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492
[TBL] [Abstract][Full Text] [Related]
2. Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis.
Druce HM; Spector SL; Fireman P; Kaiser H; Meltzer EO; Boggs P; Wood CC; Paluch EP
Ann Allergy; 1992 Jul; 69(1):53-60. PubMed ID: 1385682
[TBL] [Abstract][Full Text] [Related]
3. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis.
Ozcan C; Vayisoglu Y; Doğu O; Görür K
Am J Otolaryngol; 2006; 27(5):314-8. PubMed ID: 16935174
[TBL] [Abstract][Full Text] [Related]
4. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial.
Unal M; Sevim S; Doğu O; Vayisoğlu Y; Kanik A
Acta Otolaryngol; 2003 Dec; 123(9):1060-3. PubMed ID: 14710908
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
Eccles R; Martensson K; Chen SC
Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
[TBL] [Abstract][Full Text] [Related]
6. Intranasal ipratropium in the treatment of vasomotor rhinitis.
Jokinen K; Sipilä P
Rhinology; 1983 Dec; 21(4):341-5. PubMed ID: 6229864
[TBL] [Abstract][Full Text] [Related]
7. Intranasal ipratropium: inhibition of methacholine induced hypersecretion.
Borum P
Rhinology; 1978 Dec; 16(4):225-33. PubMed ID: 154164
[TBL] [Abstract][Full Text] [Related]
8. Nasal disorders and anticholinergic therapy.
Borum P
Postgrad Med J; 1987; 63 Suppl 1():61-8. PubMed ID: 2962076
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy.
Yang TY; Jung YG; Kim YH; Jang TY
Otolaryngol Head Neck Surg; 2008 Sep; 139(3):367-71. PubMed ID: 18722214
[TBL] [Abstract][Full Text] [Related]
10. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
Borum S; Nielsen K; Bisgaard H; Mygind N
Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
[TBL] [Abstract][Full Text] [Related]
11. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
Georgitis JW; Banov C; Boggs PB; Dockhorn R; Grossman J; Tinkelman D; Roszko P; Wood C
Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea.
Borum S; Becker B; Mygind N; Borum P
Rhinology; 1996 Dec; 34(4):198-200. PubMed ID: 9050095
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis.
Cordray S; Harjo JB; Miner L
Ear Nose Throat J; 2005 Jul; 84(7):426-30. PubMed ID: 16813032
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin therapy in the ovalbumin-sensitized rat.
Wen WD; Yuan F; Wang JL; Hou YP
Neuroimmunomodulation; 2007; 14(2):78-83. PubMed ID: 17713354
[TBL] [Abstract][Full Text] [Related]
15. Intranasal ipratropium: literature abstracts and comments.
Mygind N; Borum P
Rhinol Suppl; 1989; 9():37-44. PubMed ID: 2534054
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies for botulinum toxin type A on allergic rhinitis in the rat.
Wen WD; Yuan F; Hou YP; Song YF
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Feb; 39(2):97-101. PubMed ID: 15195592
[TBL] [Abstract][Full Text] [Related]
17. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis.
Rohrbach S; Junghans K; Köhler S; Laskawi R
Head Face Med; 2009 Oct; 5():18. PubMed ID: 19835591
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
20. [Dexpanthenol nasal spray as an effective therapeutic principle for treatment of rhinitis sicca anterior].
Kehrl W; Sonnemann U
Laryngorhinootologie; 1998 Sep; 77(9):506-12. PubMed ID: 9795928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
